Ragasa, Ysrael Edrich M.

HRN: 27-27-35  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/22/2025
06/29/2025
IV
50 Mg
Q 24
T/C Neonatal Pneumonia
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines